-
1
-
-
0029816912
-
Cancer: Science and society and the communication risk
-
Calman KC. Cancer: Science and society and the communication risk. Br Med J 1996; 313:799-802.
-
(1996)
Br Med J
, vol.313
, pp. 799-802
-
-
Calman, K.C.1
-
2
-
-
0023805341
-
Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2
-
Sleight P (Chairman) ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988; ii:349-360.
-
(1988)
Lancet
, vol.2
, pp. 349-360
-
-
Sleight, P.1
-
3
-
-
0028039957
-
Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of mortality and major morbidity results from all randomised trials of more than 1000 patients
-
Fibrinolytic Therapy Trialists' (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: Collaborative overview of mortality and major morbidity results from all randomised trials of more than 1000 patients. Lancet 1994; 343:311-322.
-
(1994)
Lancet
, vol.343
, pp. 311-322
-
-
-
4
-
-
0028128106
-
Collaborative overview of randomised trials of antiplatelet therapy. II: Maintenance of vascular graft or arterial patency by antiplatelet therapy
-
Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy. II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Br Med J 1994; 308:159-168.
-
(1994)
Br Med J
, vol.308
, pp. 159-168
-
-
-
5
-
-
84888827980
-
Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myo-cardial infarction: ISIS-1
-
Sleight P (Chairman) ISIS-1 (International Studies of Infarct Survival) Collaborative Group. Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myo-cardial infarction: ISIS-1. Lancet 1986; ii:57-66.
-
(1986)
Lancet
, vol.2
, pp. 57-66
-
-
-
6
-
-
0021222049
-
Pre- And in-hospital antiarrhythmic prevention of ventricular fibrillation complicating acute myocardial infarction
-
Lie KI. Pre- and in-hospital antiarrhythmic prevention of ventricular fibrillation complicating acute myocardial infarction. Eur Heart J 1984; 5(Suppl. B):95-97.
-
(1984)
Eur Heart J
, vol.5
, Issue.SUPPL. B
, pp. 95-97
-
-
Lie, K.I.1
-
7
-
-
0023694806
-
Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials
-
McMahon S, Collins R, Peto R, et al. Effects of prophylactic lidocaine in suspected acute myocardial infarction. An overview of results from the randomized, controlled trials. JAMA 1988; 260:1910-1916.
-
(1988)
JAMA
, vol.260
, pp. 1910-1916
-
-
McMahon, S.1
Collins, R.2
Peto, R.3
-
8
-
-
0024321898
-
Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction
-
The Cardiac Arrhythmia Suppression trial (CAST) Investigators. Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989;321: 406-412.
-
(1989)
N Engl J Med
, vol.321
, pp. 406-412
-
-
-
9
-
-
0027998462
-
Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA)
-
Doval HC, Nul DR, Grancelli HO, et al. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994; 344: 489-490.
-
(1994)
Lancet
, vol.344
, pp. 489-490
-
-
Doval, H.C.1
Nul, D.R.2
Grancelli, H.O.3
-
10
-
-
0029819626
-
Passive smoking and health: Should we believe Philip Morris's "experts"?
-
Smith GD, Phillips AN. Passive smoking and health: Should we believe Philip Morris's "experts"? Br Med J 1996; 313:929-933.
-
(1996)
Br Med J
, vol.313
, pp. 929-933
-
-
Smith, G.D.1
Phillips, A.N.2
|